Clinical and serological transition from pemphigus vulgaris to pemphigus foliaceus demonstrated by desmoglein ELISA system.
Tsuji
Yukiko
Y
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638 Japan. yutsuji@med.hokudai.ac.jp
Kawashima
Toshimitsu
T
Yokota
Koichi
K
Tateish
Yasuki
Y
Tomita
Yuki
Y
Matsumura
Tetsuri
T
Shimizu
Hiroshi
H
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001707:Biopsy, Needle; D015820:Cadherins / Q000097:blood*; D003598:Cytoskeletal Proteins / Q000097:blood; D051183:Desmoglein 1; D051182:Desmogleins; D051180:Desmoplakins; D003907:Dexamethasone / Q000008:administration & dosage; D004797:Enzyme-Linked Immunosorbent Assay; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology; D010392:Pemphigus / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
D000893:Anti-Inflammatory Agents; D015820:Cadherins; D003598:Cytoskeletal Proteins; D051183:Desmoglein 1; D051182:Desmogleins; D051180:Desmoplakins; D003907:Dexamethasone